Virtual Therapeutic Moiety (VTM) - Brexucabtagene autoleucel
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Brexucabtagene autoleucel | Start Date 11-10-2022 | End Date |
| Previous Name | Previous Name Autologous anti-CD19-transduced CD3+ cells | Start Date 04-02-2021 |
End Date
|
Codes
SNOMED Code
| Code | Start date | End date |
|---|---|---|
| Current SNOMED Code 895370000 | Start Date 06-02-2023 | End Date |
| Current SNOMED Code 39362711000001109 | Start Date 04-02-2021 | End Date 05-02-2023 |
Ingredient Details
| Name | Invalid |
|---|---|
| Brexucabtagene autoleucel |
Name
Brexucabtagene autoleucel
Virtual Medicinal Products (VMPs)
| Name | Discontinued | Invalid |
|---|---|---|
| Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags |
Name
null Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags
Discontinued
Not Discontinued
Invalid
Not Invalid